Statement Of Financial Position [Abstract]

Egetis Therapeutics - Filing #701621

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Right-of-use assets
4 088 SEK
4 666 SEK
Cash and cash equivalents
143 965 SEK
287 850 SEK
255 101 SEK
Assets
569 269 SEK
717 000 SEK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
8 688 SEK
8 688 SEK
Retained earnings
745 792 SEK
641 250 SEK
Other reserves
1 305 SEK
448,000 SEK
Equity
527 039 SEK
745 792 SEK
1 305 SEK
1 262 837 SEK
8 688 SEK
630 723 SEK
8 688 SEK
641 250 SEK
448,000 SEK
1 262 837 SEK
463 220 SEK
SEK
244 876 SEK
705 278 SEK
2 818 SEK
Equity and liabilities
569 269 SEK
717 000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.